Early Second-Trimester Serum MicroRNAs as Potential Biomarker for Nondiabetic Macrosomia

Table 2

TLDA screening results of serum miRNA expression in macrosomia and controls.

MicroRNA	Case		Control
	CT		CT
hsa-miR-1	36.01	14.06	33.97	11.97	2.09
hsa-miR-122	25.96	4.00	22.95	0.96	3.05
hsa-miR-192	27.97	6.02	25.97	3.97	2.04
hsa-miR-192-3p	35.98	14.03	33.99	11.99	2.04
hsa-miR-194	29.99	8.04	25.98	3.98	4.06
hsa-miR-296-5p	33.03	11.08	30.90	8.90	2.18
hsa-miR-301b	32.96	11.01	35.98	13.99
hsa-miR-376a	31.98	10.03	29.98	7.99	2.04
hsa-miR-487b	34.00	12.05	32.00	10.00	2.04
hsa-miR-489	35.98	14.02	33.96	11.97	2.06
hsa-miR-500	36.01	14.05	33.99	12.00	2.05
hsa-miR-505	33.02	11.06	31.00	9.00	2.06
hsa-miR-518e	32.99	11.04	35.06	13.07
hsa-miR-591	35.19	13.23	32.95	10.95	2.28
hsa-miR-625	35.97	14.01	33.96	11.97	2.05
hsa-miR-1262	35.00	13.04	32.96	10.97	2.07